HOSPITAL OVERCIEW
LATEST NEWS
undefined
Beijing Institute of Pulmonary Fibrosis is based on Beijing Kang Yi De Integrative Medicine Pulmonary Hospital, clinical, teaching, research, pharmaceutical research and development as one of the only one professional research and prevention and treatment of pulmonary fibrosis research institutions. The institute is headed by Dean Dong Rui and Yu Rujiang as honorary director. Under the leadership of two academic leaders, Dong Rui and Yu Runjiang, Beijing Institute of Pulmonary Fibrosis brings together a number of domestic experts in respiratory diseases and more than 20 professional researchers of pulmonary fibrosis, and is mainly engaged in the research on the theory of prevention and treatment of pulmonary fibrosis And Integrative Medicine prevention and treatment programs, regulate pulmonary fibrosis treatment technology programs, to carry out scientific and technological advice and services.
Beijing Institute of Pulmonary Fibrosis since its inception, and actively implement and implement the "science and technology" of the strategic approach, the research achievements have access to two national patents; access to national and municipal level of pulmonary fibrosis prevention and treatment of scientific and technological progress awards More than 10; access to the Ministry of Health, the State Administration of traditional Chinese medicine for grassroots technology promotion of suitable scientific research projects. In January 2009, the Institute published the monograph of President Dong Rui on Integrative Medicine in Diagnosis and Treatment of Pulmonary Fibrosis, which established the theoretical basis of TCM diagnosis and treatment of pulmonary fibrosis. Institute of Chinese winter medicine and winter disease treatment professional committee cooperation, published "Chinese medicine winter disease summer governance" monograph, founded the traditional Chinese medicine "winter sickness summer cure winter prevention, Chinese medicine sticking" new prevention and treatment of pulmonary fibrosis system. Institute published in the national core journals on prevention and treatment of pulmonary fibrosis more than 20 articles, becoming the only pulmonary fibrosis prevention and research institutions in our country.
Definition of Pulmonary (Interstitial) Fibrosis Disease
What is Pulmonary Fibrosis? In Western medicine, pulmonary fibrosis is a representative disease in interstitial lung disease (ILD) or diffuse interstitial lung disease (DPLD). Pulmonary fibrosis is a commonly used disease name in clinical medicine and imaging, which can be divided into two types: idiopathic pulmonary fibrosis and secondary pulmonary fibrosis.
Speaking of pulmonary fibrosis, in fact, pulmonary fibrosis is alveolar tissue scarring, alveolar gradually replaced by fibrous material, and gradually lose the diffuse function, leading to alveolar tissue hardening, thickening, the lungs gradually lose oxygen exchange capacity into the blood, leading to Patients with varying degrees of hypoxia and breathing difficulties, recurrent illness, painful, and finally died of respiratory failure. Dongrui Dean made a metaphor, if the lungs than as a sponge, the oxygen is compared to water, healthy people's lungs is like a clean, high-quality sponge, has a good water absorption